The present invention relates to cell-free larval preparations of Heligmosomoides polygyrus bakeri (Hpb) helminths, wherein said larval preparation is obtainable from cells of the L3-developmental stage larva of said Hpb helminths, wherein said larval preparation is capable of modulating the innate mammalian immune system as well as methods of making and uses thereof.

The present invention relates to cell-free larval preparations of Heligmosomoides polygyrus bakeri (Hpb) helminths, wherein said larval preparation is obtainable from cells of the L3-developmental stage larva of said Hpb helminths, wherein said larval preparation is capable of modulating the innate mammalian immune system as well as methods of making and uses thereof.

Disclosed herein is a traditional Chinese medicine composition for treating interstitial pulmonary fibrosis, which is prepared from 10-20 parts by weight of Radix salviae miltiorrhiza, 4-8 parts by weight of peach kernel, 2-4 parts by weight of hirudo, 5-15 parts by weight of Radix paeoniae rubra, 5-15 parts by weight of Radix ophiopogonis, 5-15 parts by weight of Chebulae fructus immaturus and 2-4 parts by weight of Oroxylum indicum (Linn.) Kurz. The invention also provides a method of preparing the composition.

Disclosed herein is a traditional Chinese medicine composition for treating interstitial pulmonary fibrosis, which is prepared from 10-20 parts by weight of Radix salviae miltiorrhiza, 4-8 parts by weight of peach kernel, 2-4 parts by weight of hirudo, 5-15 parts by weight of Radix paeoniae rubra, 5-15 parts by weight of Radix ophiopogonis, 5-15 parts by weight of Chebulae fructus immaturus and 2-4 parts by weight of Oroxylum indicum (Linn.) Kurz. The invention also provides a method of preparing the composition.

The present invention relates to a lyophilizate comprising at least one globin, one globin protomer or one extracellular hemoglobin of annelids, and a stabilizer chosen from disaccharides, polyols and antioxidants. The present invention also relates to a composition comprising: a solution comprising at least one globin, one globin protomer or one extracellular hemoglobin of annelids, and a stabilizer chosen from disaccharides, polyols and antioxidants.

Finally, the present invention relates to a process for preparing the lyophilizate.

The present invention relates to a lyophilizate comprising at least one globin, one globin protomer or one extracellular hemoglobin of annelids, and a stabilizer chosen from disaccharides, polyols and antioxidants. The present invention also relates to a composition comprising: a solution comprising at least one globin, one globin protomer or one extracellular hemoglobin of annelids, and a stabilizer chosen from disaccharides, polyols and antioxidants.

Finally, the present invention relates to a process for preparing the lyophilizate.

The present invention relates to an aqueous extract useful notably for the regeneration of human or animal cells, notably mammalian cells, comprising an aqueous extract free of any insoluble solid debris of ground planarian organisms having a regeneration capacity, containing at least the intracellular components of the cells of said organisms of a cell lysate of said cells of said organisms.

The present invention relates to an aqueous extract useful notably for the regeneration of human or animal cells, notably mammalian cells, comprising an aqueous extract free of any insoluble solid debris of ground planarian organisms having a regeneration capacity, containing at least the intracellular components of the cells of said organisms of a cell lysate of said cells of said organisms.

A use of a pharmaceutical composition in preparing a drug against Helicobacter pylori. The pharmaceutical composition is suitable for oral administration and comprises a homogeneous mixture of edible oil, beeswax, and β-sitosterol. The beeswax in the composition forms microcrystals. Based on the total weight of the composition, the content of the beeswax is 0.5-50%, and the content of the β-sitosterol is 0.1-20%. The pharmaceutical composition can be used in inhibiting or killing Helicobacter pylori and in treating or preventing a disease caused by Helicobacter pylori.

A use of a pharmaceutical composition in preparing a drug against Helicobacter pylori. The pharmaceutical composition is suitable for oral administration and comprises a homogeneous mixture of edible oil, beeswax, and β-sitosterol. The beeswax in the composition forms microcrystals. Based on the total weight of the composition, the content of the beeswax is 0.5-50%, and the content of the β-sitosterol is 0.1-20%. The pharmaceutical composition can be used in inhibiting or killing Helicobacter pylori and in treating or preventing a disease caused by Helicobacter pylori.